IRIDEX Total Current Assets 2010-2024 | IRIX
IRIDEX total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
IRIDEX Annual Total Current Assets (Millions of US $) |
2023 |
$27 |
2022 |
$36 |
2021 |
$42 |
2020 |
$25 |
2019 |
$31 |
2018 |
$40 |
2017 |
$39 |
2016 |
$46 |
2015 |
$31 |
2014 |
$33 |
2013 |
$32 |
2012 |
$27 |
2011 |
$30 |
2010 |
$26 |
2009 |
$26 |
IRIDEX Quarterly Total Current Assets (Millions of US $) |
2024-09-30 |
$24 |
2024-06-30 |
$25 |
2024-03-31 |
$28 |
2023-12-31 |
$27 |
2023-09-30 |
$27 |
2023-06-30 |
$31 |
2023-03-31 |
$35 |
2022-12-31 |
$36 |
2022-09-30 |
$38 |
2022-06-30 |
$39 |
2022-03-31 |
$42 |
2021-12-31 |
$42 |
2021-09-30 |
$44 |
2021-06-30 |
$44 |
2021-03-31 |
$44 |
2020-12-31 |
$25 |
2020-09-30 |
$26 |
2020-06-30 |
$26 |
2020-03-31 |
$27 |
2019-12-31 |
$31 |
2019-09-30 |
$31 |
2019-06-30 |
$33 |
2019-03-31 |
$35 |
2018-12-31 |
$40 |
2018-09-30 |
$41 |
2018-06-30 |
$33 |
2018-03-31 |
$35 |
2017-12-31 |
$39 |
2017-09-30 |
$41 |
2017-06-30 |
$44 |
2017-03-31 |
$45 |
2016-12-31 |
$46 |
2016-09-30 |
$31 |
2016-06-30 |
$33 |
2016-03-31 |
$31 |
2015-12-31 |
$31 |
2015-09-30 |
$31 |
2015-06-30 |
$32 |
2015-03-31 |
$33 |
2014-12-31 |
$33 |
2014-09-30 |
$31 |
2014-06-30 |
$30 |
2014-03-31 |
$31 |
2013-12-31 |
$32 |
2013-09-30 |
$30 |
2013-06-30 |
$30 |
2013-03-31 |
$27 |
2012-12-31 |
$27 |
2012-09-30 |
$29 |
2012-06-30 |
$29 |
2012-03-31 |
$29 |
2011-12-31 |
$30 |
2011-09-30 |
$28 |
2011-06-30 |
$27 |
2011-03-31 |
$26 |
2010-12-31 |
$26 |
2010-09-30 |
$25 |
2010-06-30 |
$24 |
2010-03-31 |
$24 |
2009-12-31 |
$26 |
2009-09-30 |
$25 |
2009-06-30 |
$25 |
2009-03-31 |
$25 |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Laser Systems and Components |
$0.029B |
$0.052B |
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|